Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

KRYSKRYS
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in Krystal Biotech, Inc.

GOLDMAN SACHS GROUP INC holds 298,841 shares of KRYS (Krystal Biotech, Inc.), worth $111.1M as of 2026-Q2. The position was increased (+39.0% shares). KRYS represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$111.1M

Current Shares

298,841

Total Value Change

+$67.6M

Total Shares Change

+21,666

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
298,841
+39.0%
$111.1M0.0%$371.67
40
2026-Q1
Decreased
214,949
-26.8%
$55.5M0.0%$263.80
0
2025-Q4
Decreased
293,525
-15.7%
$72.4M0.0%$247.88
0
2025-Q3
Decreased
348,250
-34.3%
$61.5M0.0%$176.75
0
2025-Q2
Increased
530,361
+127.0%
$72.9M0.0%$138.88
48
2025-Q1
Decreased
233,640
-15.7%
$42.1M0.0%$183.92
0
2024-Q4
New
277,175
-
$43.4M0.0%$159.80
40

Other major holders of KRYS: FMR LLC, BlackRock, Inc., Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used